Lupus anticoagulant and mortality in patients hospitalized for COVID-19

Coronavirus disease 2019 (COVID-19) is characterized by a procoagulant state that can lead to fatal thromboembolic events. Several studies have documented a high prevalence of lupus anticoagulant that may at least partially explain the procoagulant profile of COVID-19. However, the association betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Gazzaruso, Carmine, Mariani, Giuseppe, Ravetto, Carolina, Malinverni, Laura, Tondelli, Elena, Cerrone, Maria, Sala, Vittorio, Bevilacqua, Luigi, Altavilla, Teodoro, Coppola, Adriana, Gallotti, Pietro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648549/
https://www.ncbi.nlm.nih.gov/pubmed/33159639
http://dx.doi.org/10.1007/s11239-020-02335-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648549/
https://www.ncbi.nlm.nih.gov/pubmed/33159639
http://dx.doi.org/10.1007/s11239-020-02335-w

Ejemplares similares